Skip to content

Impact of Electric Bicycle Commuting among Middle-Aged Women: A Randomized Controlled Trial

Impact of Electric Bicycle Commuting among Middle-Aged Women: A Randomized Controlled Trial - Impact of Electric Bicycle Commuting among Middle-Aged Women: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058885
Enrollment
40
Registered
2025-08-26
Start date
2025-08-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Promotion

Interventions

Participants in the intervention group commuted to their workplace using an electric bicycle for approximately 15 to 20 minutes per day. Continue their usual commuting method

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Participants were required to meet all of the following criteria: 1. Women aged 40 to under 65 years. 2. Able to commute by bicycle for part of the route to their workplace. 3. Enrolled in bicycle insurance.

Exclusion criteria

Exclusion criteria: Participants were excluded if they met any of the following criteria: 1 Unable to use a smartphone. 2 Orthopedic or neurological disorders that prevent cycling or with no prior cycling experience. 3 Experiencing chest pain, dyspnea, palpitations, or joint pain in the lower limbs at rest. 4 Experiencing chest pain, dyspnea, palpitations, or joint pain in the lower limbs during daily activities. 5 Presence of metallic implants in the body. 6 Currently undergoing cardiac rehabilitation. 7 Untreated grade III hypertension or higher (systolic blood pressure 180 mmHg and/or diastolic blood pressure 110 mmHg) or hypertension accompanied by symptoms such as headache. 8 Symptomatic heart disease (e.g., coronary artery disease, valvular disease, arrhythmia, heart failure) for which a physician has restricted exercise. 9 Any other medical condition that may worsen with exercise. 10 Advised by a physician to restrict exercise.

Design outcomes

Primary

MeasureTime frame
Change in work productivity from baseline to 90 days post-intervention

Countries

Japan

Contacts

Public Contacteri kato

Center for Preventive Medicine and Lifestyle-related Diseases, Kyoto University Hospital, Kyoto, Jap Department of Cardiology

erikato@kuhp.kyoto-u.ac.jp075-751-4255

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026